Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Accolade stock
Learn how to easily invest in Accolade stock.
Accolade Inc is a health information services business based in the US. Accolade shares (ACCD) are listed on the NASDAQ and all prices are listed in US Dollars. Accolade employs 2,300 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Accolade
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – ACCD – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Accolade stock price (NASDAQ: ACCD)Use our graph to track the performance of ACCD stocks over time.
Accolade shares at a glance
|Latest market close||$20.21|
|52-week range||$18.72 - $59.93|
|50-day moving average||$29.30|
|200-day moving average||$42.29|
|Wall St. target price||$48.73|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-2.65|
Buy Accolade shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Accolade stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Accolade price performance over time
|1 week (2022-01-10)||5.59%|
|1 month (2021-12-17)||-18.01%|
|3 months (2021-10-15)||-49.48%|
|6 months (2021-07-17)||-62.55%|
|1 year (2021-01-15)||-61.39%|
|2 years (2020-01-13)||N/A|
|3 years (2019-01-13)||N/A|
|5 years (2017-01-13)||N/A|
|Revenue TTM||$230.5 million|
|Gross profit TTM||$76.7 million|
|Return on assets TTM||-8.19%|
|Return on equity TTM||-28.61%|
|Market capitalisation||$1.4 billion|
TTM: trailing 12 months
Accolade share dividends
We're not expecting Accolade to pay a dividend over the next 12 months.
Accolade, Inc. develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. It also provides second opinion consultation and health care decision support services. The company serves employers who provide their employees and their employees' families a single place to turn for their health, healthcare, and benefits needs. Accolade, Inc. was founded in 2007 and is headquartered in Plymouth Meeting, Pennsylvania.
Accolade in the news
What Percentage Of Accolade, Inc. (NASDAQ:ACCD) Shares Do Insiders Own?
Supreme Court vaccine mandate ruling won't bar companies from demanding Covid shots for workers — Biden vows to advocate for that
Accolade Inc Shares Close the Day 13.1% Lower - Daily Wrap
Frequently asked questionsWhat percentage of Accolade is owned by insiders or institutions?
Currently 3.671% of Accolade shares are held by insiders and 73.501% by institutions. How many people work for Accolade?
Latest data suggests 2,300 work at Accolade. When does the fiscal year end for Accolade?
Accolade's fiscal year ends in February. Where is Accolade based?
Accolade's address is: 660 West Germantown Pike, Plymouth Meeting, PA, United States, 19462 What is Accolade's ISIN number?
Accolade's international securities identification number is: US00437E1029 What is Accolade's CUSIP number?
Accolade's Committee on Uniform Securities Identification Procedures number is: M01690102
More guides on Finder
Can Turo’s IPO do better than Uber and Airbnb?
Car-sharing service Turo has filed plans for an IPO. What you need to know.
Monie savings review
Monie offers 5% APY on deposits, but funds aren’t insured and the interface is buggy.
Covid test stocks
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Is Berkshire Hathaway the next $1 trillion stock?
Buffett’s Berkshire Hathaway may now be on its way to becoming the next trillion-dollar company.
Tesla roars into 2022 after December drop
Record vehicle deliveries cause the Tesla stock price to move close to all-time highs.
How to buy Affinia Therapeutics (AFTX) stock when it goes public
Everything we know about the Affinia Therapeutics IPO, plus information on how to buy in.
How to buy Austin Gold (AUST) stock when it goes public
Everything we know about the Austin Gold IPO, plus information on how to buy in.
How to buy VinFast stock when it goes public
Everything we know about the VinFast IPO, plus information on how to buy in.
How to buy Nexalin Technology (NXL) stock when it goes public
Everything we know about the Nexalin Technology IPO, plus information on how to buy in.
How to buy Specialty Building Products (SBP) stock when it goes public
Everything we know about the Specialty Building Products IPO, plus information on how to buy in.
Ask an Expert